Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis
Citations Over TimeTop 10% of 2021 papers
Abstract
The gut microbiota is a potential environmental factor that influences the development of multiple sclerosis (MS). We and others have demonstrated that patients with MS and healthy individuals have distinct gut microbiomes. However, the pathogenic relevance of these differences remains unclear. Previously, we showed that bacteria that metabolize isoflavones are less abundant in patients with MS, suggesting that isoflavone-metabolizing bacteria might provide protection against MS. Here, using a mouse model of MS, we report that an isoflavone diet provides protection against disease, which is dependent on the presence of isoflavone-metabolizing bacteria and their metabolite equol. Notably, the composition of the gut microbiome in mice fed an isoflavone diet exhibited parallels to healthy human donors, whereas the composition in those fed an isoflavone-free diet exhibited parallels to patients with MS. Collectively, our study provides evidence that dietary-induced gut microbial changes alleviate disease severity and may contribute to MS pathogenesis.
Related Papers
- → Mucosal Immune Responses to Microbiota in the Development of Autoimmune Disease(2014)53 cited
- → Autoimmunity and Heavy Metals(1994)85 cited
- → Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus.(2003)78 cited
- From autoimmunity to autoimmune disease(2012)
- → Autoimmunity(2010)